Augment Health, Inc., a medical technology company developing next generation urologic monitoring tools for patients with chronic conditions, recently announced an investment from Vanderbilt University’s Innovation Investment Committee (“IIC”).
The IIC investment follows milestones the company achieved in 2023, including: a pre-clinical animal study demonstrating the technology’s accuracy, an assessment of existing health insurance coverage reimbursement models, and pre-submission work for the U.S. FDA.